The three projects will advance innovation and address challenges in a number of key areas throughout Ireland.
Three groundbreaking initiatives have secured funding under call seven of the Disruptive Technologies Innovation Fund (DTIF), which is a €500 million fund established under the 2018 National Development Plan .
Managed by the Department of Enterprise, Tourism and Employment, with administrative support from Enterprise Ireland, the fund aims to drive collaboration, research and investment among Ireland’s leading industry members, as they develop and deploy disruptive technologies.
Among the recipients of the latest cohort and the group to have received the largest award to date of almost €12m, is the consortium of Lift BioSciences, Hooke Bio and University of Galway, for their work on the N-Lift project.
This is research into options for metastatic solid tumours that are resistant to treatment and are no longer responding to therapy. Advancements in the project will enable the groups to launch the first human trial of IMAN therapy.
Ventripump, a project undertaken by CardiacBooster, Integer Holdings and Fire1, was awarded a grant of €9.3m to further develop a comprehensive medical device platform aimed at treating cardiogenic shock, a dangerous condition where your heart is suddenly unable to pump the volume of blood needed to sustain life.
The final project to receive funding is MIMRAD 5D, which was given €6.9m and works to create safer driving conditions on the roads.
Provizio Limited, Robert Bosch Ireland Limited and the University of Limerick will develop a compact, cost-effective imaging radar combining innovations from all three groups, which will aim to prevent road death and casualties through a reduction in the number of road collisions, or the serious impact of them when they do occur.
Commenting on the news, Jenny Melia, the CEO of Enterprise Ireland said, “The Disruptive Technologies Innovation Fund is about investing in bold ideas and ambitious partnerships that have the potential to deliver real impact, for our economy and for our society.
“The three projects announced today exemplify this ambition, with breakthroughs in cancer treatment, cardiac care and road safety that could save lives and transform global markets.
“Through the DTIF, we are supporting dynamic Irish companies to develop new intellectual property and to scale world-class innovation. The collaborative model is helping to anchor R&D talent in regions across the country and build strong foundations for future growth.”
Don’t miss out on the knowledge you need to succeed. Sign up for the Daily Brief, Silicon Republic’s digest of need-to-know sci-tech news.